 | • レポートコード：MRC2303E074 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、222ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：通信・IT |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社発行の当調査レポートでは、2021年に109.7億ドルであった世界のスマートバイオセンサー市場規模が、2022年に118.9億ドルに達し、2027年には178.8億ドルまで年平均8.47%成長すると予測しています。当レポートは、スマートバイオセンサーの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別（ノンウェアラブルバイオセンサー、ウェアラブルバイオセンサー）分析、技術別（電気化学バイオセンサー、ナノメカニカルバイオセンサー、光バイオセンサー、圧電バイオセンサー、熱バイオセンサー）分析、用途別（血液ガス分析、血糖値測定、コレステロール検査、創薬、その他）分析、エンドユーザー別（環境モニタリング、食品＆飲料産業、家庭診断、ポイントオブケア、その他）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でまとめております。なお、当書には、Abbott Point of Care Inc.、Acon Laboratories Inc.、Biosensors International Group、Cardea Bio Inc、Conductive Technologies Inc、Cytiva、DexCom, Inc.、EarlySense、Eastprint Incorporated、F. Hoffmann La-Roche Ltd.、Innovative Sensor Technology IST AG、LifeScan, Inc.、LifeSensors Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のスマートバイオセンサー市場規模：製品タイプ別 - ノンウェアラブルバイオセンサーの市場規模 - ウェアラブルバイオセンサーの市場規模 ・世界のスマートバイオセンサー市場規模：技術別 - 電気化学バイオセンサーの市場規模 - ナノメカニカルバイオセンサーの市場規模 - 光バイオセンサーの市場規模 - 圧電バイオセンサーの市場規模 - 熱バイオセンサーの市場規模 ・世界のスマートバイオセンサー市場規模：用途別 - 血液ガス分析における市場規模 - 血糖値測定における市場規模 - コレステロール検査における市場規模 - 創薬における市場規模 - その他用途における市場規模 ・世界のスマートバイオセンサー市場規模：エンドユーザー別 - 環境モニタリングにおける市場規模 - 食品＆飲料産業における市場規模 - 家庭診断における市場規模 - ポイントオブケアにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界のスマートバイオセンサー市場規模：地域別 - 南北アメリカのスマートバイオセンサー市場規模 アメリカのスマートバイオセンサー市場規模 カナダのスマートバイオセンサー市場規模 ブラジルのスマートバイオセンサー市場規模 ... - アジア太平洋のスマートバイオセンサー市場規模 日本のスマートバイオセンサー市場規模 中国のスマートバイオセンサー市場規模 インドのスマートバイオセンサー市場規模 韓国のスマートバイオセンサー市場規模 台湾のスマートバイオセンサー市場規模 ... - ヨーロッパ/中東/アフリカのスマートバイオセンサー市場規模 イギリスのスマートバイオセンサー市場規模 ドイツのスマートバイオセンサー市場規模 インドのスマートバイオセンサー市場規模 フランスのスマートバイオセンサー市場規模 ロシアのスマートバイオセンサー市場規模 ... - その他地域のスマートバイオセンサー市場規模 ・競争状況 ・企業情報 |
The Global Smart Biosensors Market size was estimated at USD 10.97 billion in 2021 and expected to reach USD 11.89 billion in 2022, and is projected to grow at a CAGR 8.47% to reach USD 17.88 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Smart Biosensors to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Non-wearable Biosensors and Wearable Biosensors.
Based on Technology, the market was studied across Electrochemical Biosensors, Nano Mechanical Biosensors, Optical Biosensors, Piezoelectric Biosensors, and Thermal Biosensors.
Based on Application, the market was studied across Blood Gas Analysis, Blood Glucose Testing, Cholesterol Testing, Drug Discovery, Infectious Disease Testing, and Pregnancy Testing.
Based on End User, the market was studied across Environmental Monitoring, Food and Beverage Industry, Home Diagnostics, Point-of-Care, Research Labs, and Security and Biodefense.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Smart Biosensors market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Smart Biosensors Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Smart Biosensors Market, including Abbott Point of Care Inc., Acon Laboratories Inc., Biosensors International Group, Cardea Bio Inc, Conductive Technologies Inc, Cytiva, DexCom, Inc., EarlySense, Eastprint Incorporated, F. Hoffmann La-Roche Ltd., Innovative Sensor Technology IST AG, LifeScan, Inc., LifeSensors Inc., LifeSignals Group Inc., Masimo, Medtronic PLC, NeuroSky, Inc, Nova Biomedical Corp., Pharmaco-Kinesis Corporation, Pinnacle Technology, SD Biosensor Inc., Siemens Healthcare AG, Universal Biosensors, VitalConnect, and Zimmer And Peacock Limited.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Smart Biosensors Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Smart Biosensors Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Smart Biosensors Market?
4. What is the competitive strategic window for opportunities in the Global Smart Biosensors Market?
5. What are the technology trends and regulatory frameworks in the Global Smart Biosensors Market?
6. What is the market share of the leading vendors in the Global Smart Biosensors Market?
7. What modes and strategic moves are considered suitable for entering the Global Smart Biosensors Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for modern biosensors in food processing equipment
5.1.1.2. Rising introduction of nanotechnology based biosensors
5.1.1.3. Growing demand for point of care devices among patients
5.1.2. Restraints
5.1.2.1. High cost of smart biosensors
5.1.3. Opportunities
5.1.3.1. Emerging replacement of traditional infrastructure across cities
5.1.3.2. Ongoing demand in environmental monitoring applications
5.1.4. Challenges
5.1.4.1. Lack of adequate reimbursement policies
5.2. Cumulative Impact of COVID-19
6. Smart Biosensors Market, by Product Type
6.1. Introduction
6.2. Non-wearable Biosensors
6.3. Wearable Biosensors
7. Smart Biosensors Market, by Technology
7.1. Introduction
7.2. Electrochemical Biosensors
7.3. Nano Mechanical Biosensors
7.4. Optical Biosensors
7.5. Piezoelectric Biosensors
7.6. Thermal Biosensors
8. Smart Biosensors Market, by Application
8.1. Introduction
8.2. Blood Gas Analysis
8.3. Blood Glucose Testing
8.4. Cholesterol Testing
8.5. Drug Discovery
8.6. Infectious Disease Testing
8.7. Pregnancy Testing
9. Smart Biosensors Market, by End User
9.1. Introduction
9.2. Environmental Monitoring
9.3. Food and Beverage Industry
9.4. Home Diagnostics
9.5. Point-of-Care
9.6. Research Labs
9.7. Security and Biodefense
10. Americas Smart Biosensors Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Smart Biosensors Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Smart Biosensors Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Point of Care Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Acon Laboratories Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Biosensors International Group
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Cardea Bio Inc
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Conductive Technologies Inc
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Cytiva
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. DexCom, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. EarlySense
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Eastprint Incorporated
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. F. Hoffmann La-Roche Ltd.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Innovative Sensor Technology IST AG
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. LifeScan, Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. LifeSensors Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. LifeSignals Group Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Masimo
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Medtronic PLC
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. NeuroSky, Inc
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Nova Biomedical Corp.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Pharmaco-Kinesis Corporation
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Pinnacle Technology
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. SD Biosensor Inc.
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Siemens Healthcare AG
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Universal Biosensors
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. VitalConnect
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
14.25. Zimmer And Peacock Limited
14.25.1. Business Overview
14.25.2. Key Executives
14.25.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing